After several years of robust expansion, the leading branded pharma companies will see growth slow to just 1.3% from now to 2015, independent market analyst company Datamonitor said in a new report. The primary culprit: expirin…
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the…
Swiss pharmaceutical giant Roche (RHHBY) said Wednesday it is slashing 6% of its workforce, or 4,800 jobs, most of them in the U.S. This is part of the drugmaker’s plan to get a handle on costs, which comes in response to recent drug setbacks and as th…
With few exceptions, investors should run screaming from any stock quoted on the Pink Sheets. But not every over-the-counter stock is a dud. In fact, some of them are top-notch global companies. Here are some major companies li…